Determining the appropriate retatrutide amount is critically necessary for obtaining desired outcomes . Initially, patients typically commence with a low quantity of approximately 2.4 mg, given every week via subcutaneous . This starting dose is then gradually boosted every four periods, up to a peak dose of 10.8 mg, according to patient effect an